NYSE:DVA (USA) Also Trade In: Brazil Germany UK

DaVita Inc $ 56.72 1.05 (1.89%)

Volume:

1,292,892

Avg Vol (1m):

2,841,769

Market Cap $:

9.09 Bil

Enterprise Value $:

17.74 Bil

P/E (TTM):

17.30

P/B:

2.32

Earnings Power Value	-22.38
Net Current Asset Value	-56.9
Tangible Book	-17.61
Projected FCF		73.69
Median P/S Value		78.26
Peter Lynch Value		23.03
DCF (FCF Based)		71.14
DCF (Earnings Based)		43.62
	Price: $56.72

5D 3M YTD 1Y 5Y 10Y All 1Y (-%)

View Full Chart

What is PE Ratio (TTM)?

Current and historical daily P/E ratio for DVA (DaVita) from 1995 to Oct 16 2019. The price to earnings ratio is calculated by taking the current stock price and dividing it by the most recent trailing twelve-month earnings per share (EPS) number. The data is updated every 20 minutes during market hours. The P/E ratio can be viewed as the number of years it takes for the company to earn back the price you pay for the stock. Therefore, lower-P/E stocks are more attractive than higher P/E stocks so long as the P/E ratio is positive. Also for stocks with the same P/E ratio, the one with faster growth business is more attractive. DaVita stock (DVA) PE ratio as of Oct 16 2019 is 69.18. More Details

DaVita PE Ratio (TTM) Chart

EMBED

DaVita PE Ratio (TTM) Historical Data

View and export this data going back to 1995. Start your Free Trial

Total 1248

DaVita PE Ratio (TTM) Historical Data
Date	PE Ratio (TTM) Data	Date	PE Ratio (TTM) Data
2019-10-16	69.2	2019-08-14	70.9
2019-10-15	69.2	2019-08-13	72.4
2019-10-14	67.9	2019-08-12	72.0
2019-10-11	68.8	2019-08-09	72.8
2019-10-10	68.1	2019-08-08	72.9
2019-10-09	67.3	2019-08-07	72.9
2019-10-08	66.1	2019-08-06	71.9
2019-10-07	67.9	2019-08-05	71.5
2019-10-04	68.3	2019-08-02	73.3
2019-10-03	68.1	2019-08-01	72.4
2019-10-02	67.8	2019-07-31	73.0
2019-10-01	69.1	2019-07-30	73.3
2019-09-30	69.6	2019-07-29	72.8
2019-09-27	68.7	2019-07-26	72.4
2019-09-26	68.3	2019-07-25	71.9
2019-09-25	70.5	2019-07-24	72.6
2019-09-24	70.0	2019-07-23	72.3
2019-09-23	72.4	2019-07-22	71.7
2019-09-20	73.2	2019-07-19	68.4
2019-09-19	72.9	2019-07-18	69.2
2019-09-18	74.8	2019-07-17	69.1
2019-09-17	75.2	2019-07-16	70.4
2019-09-16	77.2	2019-07-15	69.5
2019-09-13	75.4	2019-07-12	69.4
2019-09-12	73.5	2019-07-11	68.8
2019-09-11	72.9	2019-07-10	66.7
2019-09-10	75.2	2019-07-09	64.1
2019-09-09	74.6	2019-07-08	67.7
2019-09-06	72.4	2019-07-05	71.1
2019-09-05	70.7	2019-07-04	70.0
2019-09-04	72.1	2019-07-03	70.0
2019-09-03	71.4	2019-07-02	69.2
2019-09-02	68.7	2019-07-01	68.4
2019-08-30	68.7	2019-06-28	68.6
2019-08-29	67.7	2019-06-27	78.0
2019-08-28	66.4	2019-06-26	77.2
2019-08-27	65.6	2019-06-25	76.4
2019-08-26	67.1	2019-06-24	75.2
2019-08-23	66.7	2019-06-21	74.8
2019-08-22	68.2	2019-06-20	73.8
2019-08-21	69.0	2019-06-19	72.2
2019-08-20	68.2	2019-06-18	70.1
2019-08-19	69.5	2019-06-17	69.4
2019-08-16	70.5	2019-06-14	68.9
2019-08-15	71.2	2019-06-13	69.1

DaVita PE Ratio (TTM) Comparison

Company	Market Cap(Mil)	PE Ratio (TTM)

Business Description

Industry Health Care Providers » Health Care Providers NAICS : 621492 NAICS : 8092

Compare ASX:SHL ASX:RHC BSP:HAPV3 HKSE:00708 LSE:NMC NYSE:CHE NYSE:EHC XKLS:5225 BKK:BDMS NYSE:UHS SHSE:600763 NAS:AMED BKK:BH-Q HKSE:01951 NAS:LHCG LSE:MDC GREY:HSCPF SZSE:300015 NSE:APOLLOHOSP NAS:ACHC

Traded in other countries DVAI34.Brazil TRL.Germany 0I7E.UK DVA.USA

Address 2000 16th Street, Denver, CO, USA, 80202

DaVita is the world's second- largest dialysis provider, with most of its 2,700 clinics based in the U.S. The company treats nearly 220,000 patients with end-stage renal disease. The company has just over 200 clinics in markets outside the U.S. DaVita recently decided to sell its medical group business--which was originally acquired in 2012 under the name HealthCare Partners--for $4.9 billion.

Product

Business

Information

About

Affiliate Program

Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names

Earn affiliate commissions by embedding GuruFocus Charts

GuruFocus Affiliate Program: Earn up to $400 per referral. Learn More

Disclaimers

GuruFocus.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The gurus may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes provided by InterActive Data. Fundamental company data provided by Morningstar, updated daily.